Strategic partnerships Leverage NLC Health Ventures' collaboration with Verily and its track record of joint ventures such as Serda Therapeutics to identify co-development and commercialization opportunities with biotech firms that require healthtech integration, funding, and go-to-market support.

Portfolio growth Target late-stage healthtech startups in NLC's existing ecosystem (MindAffect, Exolvo Biosciences, Serda Therapeutics) for expansion capital, strategic advisory, and platform services to accelerate clinical deployment and scale patient reach.

Afforded funding With recent financings and a revenue range of one to ten million, position as a value-add investor offering growth capital, strategic introductions, and pilot programs for ventures seeking large-scale payer contracts and hospital system adoption.

Technical enablement Capitalize on NLC's tech stack usage and digital presence to offer integration partnerships, data analytics collaborations, and HIPAA-compliant health IT solutions for portfolio companies and external health systems seeking interoperability.

Market expansion Identify opportunities in vascular surgery, CAD patient care, and biologic drug delivery spaces where NLC has shown interest, proposing pilot collaborations, clinical trial support, and reimbursement strategy services to accelerate market entry.